Do I need FDA approval to sell private label hydrocolloid patches in the US?

The short answer depends entirely on your claims and your active ingredients. As of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), cosmetic products sold in the US require facility registration and product listing with the FDA, but they do not require pre-market approval. A plain hydrocolloid patch with no drug-active ingredients (no salicylic acid, benzoyl peroxide, or sulfur) marketed with only cosmetic claims — such as 'absorbs impurities,' 'protects blemishes overnight,' or 'hydrates skin' — is a cosmetic product and follows the cosmetic regulatory pathway.

Under MoCRA, cosmetic facilities must register with the FDA by December 29, 2023 (large companies) or December 29, 2024 (small businesses with under $1M in average annual sales). Product listings must be submitted biennially. Your manufacturer's US facility should already be registered; if they are not, that is a red flag. If you are importing from a foreign manufacturer, you as the US responsible party must ensure the listing is completed.

If your patch contains salicylic acid at 0.5–2% and you make any acne-treatment claim — even something as seemingly mild as 'fights acne-causing bacteria' — the product is classified as an OTC drug under the FDA Acne Drug Products Monograph (21 CFR Part 333). OTC drugs do not require pre-market approval if they conform to the relevant monograph, but they do require a Drug Facts panel, an NDC number, and manufacturing in a facility registered under 21 CFR Parts 207 and 211 (pharmaceutical GMP), not cosmetic GMP. The compliance cost of the OTC drug pathway is substantially higher.

For EU market entry, no pre-market approval exists, but you must have a completed Product Information File (PIF), a Cosmetic Product Safety Report (CPSR) signed by a qualified EU safety assessor, an EU Responsible Person, and CPNP notification before the product can be placed on the market. Allow 8–16 weeks and $1,500–$4,000 for the safety report alone.

The common mistake first-timers make is writing marketing copy before they've finalized their regulatory category. Your packaging copy and claims must be reviewed by a regulatory consultant or cosmetic chemist before going to print. AJ Cosmo Labs connects you with formulators and compliance-aware manufacturers who can flag these issues during the brief stage, before you've spent money on packaging design.